Delivery Order SPE2DB22D2108-SPE2DB25FU4EW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) under a firm fixed-price contract valued at $1,947.21, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime...
- The Defense Logistics Agency awarded a $3,836.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Vaxelis vaccine syringes in 0.5ML quantities. The order, which is non-set-aside and competitively awarded, has an ultimate completion date of April 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $2,557.92 under a firm fixed-price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and utilized no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency has awarded a delivery order valued at $6,394.81 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) with a firm fixed price structure. This non-set-aside contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,958.90 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Vaxelis vaccine syringes (0.5mL) with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-set-aside award and will be fulfilled at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,800.80 delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is classified as a child contract, indicating it derives from a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) under a firm fixed price contract valued at $4,479.45. This non-competitive delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU4EWDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5ml) valued at $3,150.30 with a firm fixed price structure. The contract, issued on April 25, 2025, with an ultimate completion date of April 28, 2025, represents a non-competitive set-aside award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that provides comprehensive global pharmaceutical and medical supply support. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds significant federal contracting relationships with the Defense Logistics Agency and serves critical medical procurement needs for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies on a competitive basis. Through the SPE2DX prime vendor contract, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, syringes, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/25/25 |